Congressmen Mike Michaud (R-ME), Dan Burton (R-IN) and TimRyan (D-OH) wrote House Energy and Commerce calling for a hearing to examinealleged conflicts of interest involving FDA’s decision not to approve Provenge.They said “there is reason to believe that serious ethics rules were violatedby two FDA advisory panel members.”
From the February 01, 2008 Issue of MM+M - Medical Marketing and Media